Erin Bailey

We’re hiring! Please help us amplify this link and spread the word to any interested oncology pharmacist looking for a meaningful career change 💯 @huntsmancancer @makala_pace @JordanOncRx @DrEmmaJones @ebailey03 @CWagnerPharmD @KLratermann employment.utah.edu/salt-lake-city…

✨PROMOTION SPOTLIGHT✨ last but certainly not least, four new team leads! Emma Jones & Erin Bailey will lead IP + OP oncology, while Stacy Prelewicz & Charlotte Wagner will lead IP + OP heme/BMT - all are PharmD & BCOP certified rockstars 🔥✅ #oncopharm #leadership

@NEJM Bleomycin rash

A 72-year-old man presented to the emergency department with a 2-day history of an itchy rash on his back. On physical examination, edematous, flagellate plaques and linear patches were present across the patient’s entire back and upper buttocks. 1/2

@neerajaiims @huntsmancancer and @CaPsurvivorship @DanaFarber discuss results from the #TALAPRO-2 phase 3 trial, showing a 36% reduction in risk of radiographic progression in patients with #mCRPC treated with talazoparib and enzalutamide. #WatchNow > bit.ly/3y6ih5n

Selecting an Optimal Second-Line Regimen for mRCC @TiansterZhang @neerajaiims @montypal @BradMcG04 #kcsm onclive.com/peer-exchange/…

@DanORx22 @UofUHealth @sue_childress @Dr_RaviMadan @UroDocAsh @JeffLittle76 @aliflynngaffney @ASHPOfficial @KevinFitz001 @MattGalsky @manuelmaiamd @Pa2fixyou @YPSLC @uga2uk @FloridaPharmDir #qygyracufjgyb&32633" target="_blank" rel="nofollow noopener">goo.gl/pg2PeX#qygyrac…

@onco_logic @ChemoExperts @Dave_Gill_SLC @CassiaGriswold @IKCCorg @soufianeraki3 @ebwcra @jeremyshumate @neerajaiims @burneysunderz @re_kemi @OncInfo @foxerinr @Ksizzly6 @TCSociety @brandonrratliff #qyhazozovakjs&48152" target="_blank" rel="nofollow noopener">goo.gl/SkZ72C#qyhazoz…

I just wrote a review on Rustic Frames - 16x20 Barnwood Frame with .5 inch Alder Inset yotpo.com/go/aTYPpkeE via @yotpo

@neerajaiims selected as mentor of the year for the @UUtah Internal Medicine department! @huntsmancancer

Great oral abstract presentation by Camryn Froerer and @ebailey03 on abx and response to VEGF TKIs. @neerajaiims @huntsmancancer

Attendance exploding, great start #gu18, videos and talk available on GUCASYM.ORG @cnsternberg @KCA_Journal @montypal @OncoBellmunt

Fantastic discussion of SPARTAN and PROSPER trials by @DrPhilKantoff #gu18: exciting development BUT true clinical benefit needs to be determined based on better scrutiny of toxicities @CancerDotNet @ConquerCancerFd @ASCO

@montypal @ASCO @PCF_Science @PCFnews @neerajaiims @TDorffOnc @wandering_gu @soulehoward1 @DrChoueiri @PauloBergerot @FabioSchutz78 @mishabeltran @morr316 I would get a Axumin PET and call it M1

@montypal @ASCO @PCF_Science @PCFnews @TDorffOnc @wandering_gu @soulehoward1 @DrChoueiri @PauloBergerot @FabioSchutz78 @mishabeltran @morr316 Bottom line is that this is a vanishing Patient population as mentioned by @Prof_Nick_James and not sure about the implications of these results in the real world in the near future

Looking forward to all the excitement of sharing the cutting edge data from #GU18 with @ERPlimackMD @PauloBergerot @OncoBellmunt @CancerDotNet @ConquerCancerFd @ASCO twitter.com/asco/status/96…

PARP inhibition+PD-1 axis inhibitor with Olaparib + durvalumab in mCRPC after enza in biomarker UNSELECTED Patients: promising PFS by Fatima Karzai @nciccr_gmb #gu18 @CancerDotNet

BOARD E21 (Abstract 584) Targeting bacteroides in the stool microbiome and response to treatment with first-line VEGFTKI in mRCC By Sidney VanAlstine @OncHahn @neerajaiims buff.ly/2Ea3856 #GU18 @ASCO

Proud of our pharmacy student: #GU18 rapid fire oral abstract: improved PFS on VEGFTKI with bacteroids targeting Antibiotics based on lab data from @montypal @cityofhope: coauthors @OncHahn @ebailey03: these studies are possible d/t IMDC Utah dataset @DrChoueiri @DrDanielHeng twitter.com/paulobergerot/…